The people behind MAASTY

RadPoly was founded by the scientists who invented MAASTY — with deep roots in polymer chemistry, structural biology, and membrane protein research.

Anton A. A. Autzen

Anton A. A. Autzen, PhD

Co-Founder & CSO  ·  Associate Professor, DTU Health Tech

Anton leads the Nanosmithery at DTU Health Tech, where his group develops functional polymers for native nanodisc technology, drug delivery, and immunoengineering. He is co-inventor of the AASTY technology (Smith & Autzen et al., Chem 2020) and the driving force behind the MAASTY platform.

Postdoctoral training: Zelikin Lab (Aarhus University), Ting Xu Lab (UC Berkeley), Appel Lab (Stanford University).
Co-founder: Polyceutix. Elected member: Det Unge Akademi, Royal Danish Academy of Sciences and Letters.

Henriette E. Autzen

Henriette E. Autzen, PhD

Co-Founder  ·  Associate Professor, Dept. of Biomedical Sciences, University of Copenhagen

Henriette is a structural biologist and cryo-EM specialist whose research centres on the structural and functional characterisation of mammalian membrane proteins — including ion channels, GPCRs, and P-type ATPases. She determined the first structure of human TRPM4 in a lipid nanodisc (Autzen et al., Science 2018) and is co-inventor of the AASTY and MAASTY polymer platforms. The 3.5 Å MAASTY nanodisc structure of TRPM4 published in Nature Communications (2025) is the first cryo-EM structure from her Copenhagen laboratory.

PhD: Nissen Lab, Aarhus University. Postdoctoral training: Dept. of Biomedical Sciences, UCPH; Cheng Lab, University of California, San Francisco.
Co-founder: Polyceutix. Funded by Novo Nordisk Foundation Hallas Møller Emerging Investigator, Carlsberg Foundation, and The Lundbeck Foundation.

The RadPoly team is growing. Postdocs, students, and collaborators contributing to polymer synthesis and quality control will be listed here as the company develops.

Work with the team

The Nanosmithery is actively engaged in research collaborations with academic and industry partners. Interested in membrane proteins, native lipid nanodiscs, or polymer-based drug delivery? Reach out.


Contact the Team